This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
I'm LongbridgeAI, I can summarize articles.Wall Street analysts initiated bullish coverage on five stocks: TRAX, BGSI, NPCE, CUE, and NGVC. Evercore ISI rated TRAX Outperform with a $65 target; Mizuho rated BGSI Outperform at $120; Keybanc rated NPCE Overweight at $18; B. Riley rated CUE Buy at $83; and BofA rated NGVC Buy at $35.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Evercore ISI Group initiated coverage on First Tracks Biotherapeutics Inc (NASDAQ:TRAX) with an Outperform rating and announced a price target of $65. First Tracks closed at $39.20 on Thursday. See how other analysts view this stock.
- Mizuho analyst David Bellinger initiated coverage on Boyd Group Services Inc (NYSE:BGSI) with an Outperform rating and announced a price target of $120. Boyd Group shares closed at $81.00 on Thursday. See how other analysts view this stock.
- Keybanc analyst Brett Fishbin initiated coverage on Neuropace Inc (NASDAQ:NPCE) with an Overweight rating and announced a price target of $18. NeuroPace closed at $14.15 on Thursday. See how other analysts view this stock.
- B. Riley Securities analyst Mayank Mamtani initiated coverage on Cue Biopharma Inc (NASDAQ:CUE) with a Buy rating and announced a price target of $83. Cue Biopharma shares closed at $37.84 on Thursday. See how other analysts view this stock.
- B of A Securities analyst Vicky Liu initiated coverage on Natural Grocers by Vitamin Cottage Inc (NYSE:NGVC) with a Buy rating and announced a price target of $35. Natural Grocers closed at $29.32 on Thursday. See how other analysts view this stock.
Considering buying CUE stock? Here’s what analysts think:
Photo via Shutterstock